Swedish Orphan Biovitrum AB (SWOBY)
23.28
0.00 (0.00%)
USD |
OTCM |
Jun 09, 16:00
Swedish Orphan Biovitrum Total Assets (Quarterly) : 8.530B for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 8.530B |
| December 31, 2025 | 7.315B |
| September 30, 2025 | 7.120B |
| June 30, 2025 | 7.214B |
| March 31, 2025 | 6.981B |
| December 31, 2024 | 6.828B |
| September 30, 2024 | 7.122B |
| June 30, 2024 | 6.909B |
| March 31, 2024 | 6.969B |
| December 31, 2023 | 7.346B |
| September 30, 2023 | 6.956B |
| June 30, 2023 | 7.016B |
| March 31, 2023 | 5.199B |
| December 31, 2022 | 5.038B |
| September 30, 2022 | 4.590B |
| June 30, 2022 | 4.726B |
| March 31, 2022 | 5.237B |
| December 31, 2021 | 5.375B |
| September 30, 2021 | 5.342B |
| June 30, 2021 | 5.402B |
| March 31, 2021 | 5.529B |
| December 31, 2020 | 5.907B |
| September 30, 2020 | 4.931B |
| June 30, 2020 | 4.577B |
| March 31, 2020 | 4.686B |
| Date | Value |
|---|---|
| December 31, 2019 | 4.877B |
| September 30, 2019 | 3.335B |
| June 30, 2019 | 3.252B |
| March 31, 2019 | 3.231B |
| December 31, 2018 | 1.938B |
| September 30, 2018 | 1.829B |
| June 30, 2018 | 1.355B |
| March 31, 2018 | 1.360B |
| December 31, 2017 | 1.332B |
| September 30, 2017 | 1.357B |
| June 30, 2017 | 1.266B |
| March 31, 2017 | 1.157B |
| December 31, 2016 | 1.108B |
| September 30, 2016 | 1.144B |
| June 30, 2016 | 1.132B |
| March 31, 2016 | 1.053B |
| December 31, 2015 | 1.012B |
| September 30, 2015 | 795.51M |
| June 30, 2015 | 789.27M |
| March 31, 2015 | 766.00M |
| December 31, 2014 | 844.16M |
| September 30, 2014 | 883.79M |
| June 30, 2014 | 934.28M |
| March 31, 2014 | 959.94M |
| December 31, 2013 | 1.015B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Hansa Biopharma AB | 122.00M |
| BioArctic AB | 281.25M |
| Diamyd Medical AB | 28.11M |
| BONESUPPORT HOLDING AB | 117.45M |
| BioInvent International AB | 56.16M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 4.291B |
| Shareholders Equity (Quarterly) | 4.238B |
| Debt to Equity Ratio | 0.4721 |
| Current Ratio | 0.7048 |
| Net Debt Paydown Yield | -0.72% |